We are keen to ensure your research study gets maximum reach and attention among the research and professional communities. Following are certain recommendations that may help you enhance the visibility of your work.
Create ORCID ID and update your list of publications on ORCID
Sign up on KUDOS website. Claim and explain your article. Share it with the research and professional community online via KUDOS
Generate Shareable-PDF of the explanation you have given for your article on Kudos. Share this PDF via ResearchGate, Academia, Mendeley and other research platforms.
Explain your work on Wikipedia
Create your own webpage and publish updates on freely accessible articles
Present your work at Conferences (you can let us know which conferences you are attending and we can provide you with promotional material for your articles)
Create accounts on Social Media platforms, for e.g. Blogging websites, Facebook, Twitter, LinkedIn, Youtube, Gmail and other Google web applications. Publish posts to project your research on these media
Join LinkedIn Groups relevant to your area of research and publish posts to project your article to the Group members
These activities can help you spread your work among the relevant audience, and provide the opportunity to increase readership and citations.
Claudiu T. Supuran (90591 citations) Neurofarba Department University of Florence Florence (Italy) Biography
Biography of Claudiu T. Supuran
CLAUDIU T. SUPURAN is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).